NEUROCRINE BIOSCIENCES INC (NBIX)

US64125C1099 - Common Stock

134.005  -6.47 (-4.61%)

Buy % Consensus

82

ChartMill assigns a Buy % Consensus number of 82% to NBIX. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 161.77. This target is 20.72% above the current price.
NBIX was analyzed by 34 analysts. The buy percentage consensus is at 82. So analysts seem to be very confident about NBIX.
In the previous month the buy percentage consensus was at a similar level.
NBIX was analyzed by 34 analysts, which is quite many. So the average rating should be quite meaningful.

Price Target & Forecast

Price Low Median Mean High 134.01112.11163.20161.77226.80 - -16.34% 21.79% 20.72% 69.25%
Up and Down Grades
Date Firm Action Rating
2024-05-29 Wedbush Reiterate Outperform -> Outperform
2024-05-28 UBS Maintains Buy -> Buy
2024-05-14 Evercore ISI Group Initiate Outperform
2024-05-03 Citigroup Maintains Neutral -> Neutral
2024-05-02 Guggenheim Maintains Buy -> Buy
2024-05-02 BMO Capital Maintains Market Perform -> Market Perform
2024-05-02 Needham Reiterate Hold
2024-05-02 Oppenheimer Maintains Outperform -> Outperform
2024-05-02 Barclays Maintains Overweight -> Overweight
2024-05-02 Canaccord Genuity Maintains Buy -> Buy
2024-05-02 HC Wainwright & Co. Maintains Buy -> Buy
2024-05-01 Needham Reiterate Hold
2024-04-24 Oppenheimer Maintains Outperform -> Outperform
2024-04-24 Wells Fargo Upgrade Equal-Weight -> Overweight
2024-04-24 HC Wainwright & Co. Reiterate Buy -> Buy
2024-04-23 Needham Reiterate Hold
2024-04-17 Wedbush Reiterate Outperform -> Outperform
2024-04-10 Cantor Fitzgerald Reiterate Overweight -> Overweight
2024-03-20 JP Morgan Maintains Overweight -> Overweight
2024-03-13 Oppenheimer Maintains Outperform -> Outperform
2024-02-23 JP Morgan Maintains Overweight -> Overweight
2024-02-08 Mizuho Maintains Neutral -> Neutral
2024-02-08 Wells Fargo Maintains Equal-Weight -> Equal-Weight
2024-02-08 Citigroup Maintains Neutral -> Neutral
2024-01-25 Goldman Sachs Maintains Buy -> Buy
2024-01-23 Barclays Maintains Overweight -> Overweight
2023-12-18 Stifel Maintains Buy -> Buy
2023-12-13 Wells Fargo Maintains Equal-Weight -> Equal-Weight
2023-12-13 Citigroup Initiate Neutral
2023-12-12 Deutsche Bank Initiate Buy